Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia
Abstract
Objective To study the effect of drugs on the hypothalamo-pituitary-gonadal (HPG) axis we compared the endocrine actions of two neuroleptics with different receptor affinity profiles-risperidone and olanzapine in male schizophrenic patients.Methods We investigated the levels of prolactin, estradiol, testosterone, LH, FSH and testicular peptide hormone-inhibin B, and we assessed psychopathology (PANSS), sexual function (ASEX) and treatment adherence (DAI-10) in 89 male schizophrenic inpatients treated with olanzapine or risperidone administered orally. The initial and final evaluations were carried out at weeks 3 and 8 after the onset of treatment, respectively.Results At initial evaluation the mean serum prolactin and inhibin B levels were markedly higher, whereas testosterone level was lower in patients treated with risperidone, than in those treated with olanzapine. In 5 out of 50 subjects from risperidone group (10%) and in 1 from olanzapine group (2.6%) testosterone levels were below the lower limit (<241ng/ml), which reflected Leydig's cell impairment. In one patient receiving risperidone and in three receiving olanzapine, inhibin B level was below 80pg/ml, indicating Sertoli's cell dysfunction. At the final evaluation the mean serum prolactin level was markedly higher in patients taking risperidone, whereas their FSH levels were lower than in patients receiving olanzapine. In all investigated groups, except for the risperidone-hyperprolactinemic group inhibin B levels were negatively correlated with serum FSH. The mean LH, FSH, testosterone and estradiol levels were within the normal reference range at initial and final evaluation. The non-adherence to medications and ASEX scores were significantly higher in risperidone groups. Sexual dysfunction and medication non-adherence was not related to prolactin or gonadal hormone levels.Conclusions Risperidone elicited higher PRL elevation than olanzapine. Treatment with this medication can be associated with disturbances in reproductive hormones (testosterone) and gonadotropins (FSH). The cause of olanzapine-elicited reduction of inhibin B level and the lack of negative correlation between FSH and inhibin B in patients with risperidone-induced hyperprolactinemia require further investigation. Patients receiving risperidone showed higher level of sexual dysfunction and treatment non-adherence than those treated with olanzapine.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Only few studies have directly compared the sexual functioning associated with different atypical antipsychotics.
“To date, only few studies (534-547) have directly compared the sexual functioning associated with different atypical AP.”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [534]
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · see citing works
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155 · see citing works
Hogan, T. P., Awad, A. G., & Eastwood, R. (1983) · Psychological Medicine · doi:10.1017/s0033291700050182 · Cited by 1,027 · see citing works
Body mass index in relation to semen quality and reproductive hormonesamong 1,558 Danish men
Jensen, T. K., Andersson, A., Jørgensen, N., Andersen, A., Carlsen, E., Petersen, J. H., & Skakkebæk, N. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.056 · Cited by 818 · see citing works
Kapur, S., Zipursky, R. B., & Remington, G. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.286 · Cited by 711 · see citing works
Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634 · see citing works
Predictors of Noncompliance in Patients With Schizophrenia
Perkins, D. O. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1206 · Cited by 546 · see citing works
Randomised controlled trial of compliance therapy
Kemp, R., Kirov, G., Everitt, B. J., Hayward, P., & David, A. S. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.172.5.413 · Cited by 525 · see citing works
Kinon, B. J., Gilmore, J. A., Liu, H., & Halbreich, U. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00127-0 · Cited by 350 · see citing works
Huang, M., Peer, A. V., Woestenborghs, R. J. H., Coster, R. D., Heykants, J., Jansen, A. A. I., Żylicz, Z., Visscher, H. W., & Jonkman, J. H. G. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.146 · Cited by 316 · see citing works
Prolactin Levels and Adverse Events in Patients Treated with Risperidone
Kleinberg, D. L., Davis, J. M., Coster, R. D., van Baelen, B., & Brecher, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00011 · Cited by 307 · see citing works
Inhibin B in male reproduction: pathophysiology and clinical relevance
Meachem, S., Nieschlag, E., & Simoni, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450561 · Cited by 291 · see citing works
Beasley, C. M., Hamilton, S. H., Crawford, A. M., Dellva, M. A., Tollefson, G. D., Trân, P. V., Blin, O. J., & Beuzen, J. N. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00392-6 · Cited by 277 · see citing works
Lambert, M., Conus, P., Eide, P., Mass, R., Karow, A., Moritz, S., Golks, D., & Naber, D. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.06.031 · Cited by 268 · see citing works
Fulton, B., & Goa, K. L. (1997) · Drugs · doi:10.2165/00003495-199753020-00007 · Cited by 251 · see citing works
Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects
Halbreich, U. M., Kinon, B. J., Gilmore, J. A., & Kahn, L. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00112-9 · Cited by 250 · see citing works
Prolactin and antipsychotic medications: mechanism of action
Petty, R. G. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00158-3 · Cited by 231 · see citing works
Kumanov, P., Nandipati, K. C., Tomova, A., & Agarwal, A. K. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.022 · Cited by 210 · see citing works
Breier, A. F., Malhotra, A. K., Su, T., Pinals, D. A., Elman, I., Adler, C. M., Lafargue, R. T., Clifton, A. D., & Pickar, D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.294 · Cited by 207 · see citing works
A PET Study of the Pathophysiology of Negative Symptoms in Schizophrenia
Potkin, S. G., Alva, G., Fleming, K., Anand, R., Keator, D. B., Carreon, D., Doo, M., Jin, Y., Wu, J. C., & Fallon, J. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.227 · Cited by 201 · see citing works
What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?
Knegtering, H., van der Moolen, A. E. G. M., Castelein, S., Kluiter, H., & van den Bosch, R. J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00130-0 · Cited by 196 · see citing works
Crawford, A. M., Beasley, C. M., & Tollefson, G. D. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00036-4 · Cited by 185 · see citing works
Sexual dysfunction and antipsychotic treatment
Cutler, A. J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00113-0 · Cited by 176 · see citing works
Sexuality and Schizophrenia: A Review
Kelly, D. L., & Conley, R. R. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007130 · Cited by 164 · see citing works
In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug.
Bymaster, F. P., Rasmussen, K. G., Calligaro, D. O., NELSON, D. A., DeLapp, N. W., Wong, D. T., & Moore, N. A. (1997) · PubMed · Cited by 162 · see citing works
Neuroleptic-induced hyperprolactinemia
Dickson, R. A. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00159-5 · Cited by 148 · see citing works
A Randomized Open-Label Study of the Impact of Quetiapine Versus Risperidone on Sexual Functioning
Knegtering, R., Castelein, S., Bous, H., van der Linde, J., Bruggeman, R., Kluiter, H., & van den Bosch, R. J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000106220.36344.04 · Cited by 147 · see citing works
Akhondzadeh, S., Rezaei, F., Larijani, B. A., Nejatisafa, A., Kashani, L., & Abbasi, S. H. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.02.008 · Cited by 136 · see citing works
Inhibin B in men with normal and disturbed spermatogenesis
Klingmüller, D., & Haidl, G. (1997) · Human Reproduction · doi:10.1093/humrep/12.11.2376 · Cited by 136 · see citing works
Dossenbach, M., Dyachkova, Y., Pirildar, S., Anders, M., Khalil, A., Araszkiewicz, A., Shakhnovich, T., Akram, A., Pecenak, J., McBride, M., et al. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2005.12.005 · Cited by 121 · see citing works
Shirayama, Y. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00367-x · Cited by 120 · see citing works
Allenby, G., Foster, P. M. D., & Sharpe, R. M. (1991) · Endocrinology · doi:10.1210/endo-128-1-467 · Cited by 105 · see citing works
Sexual dysfunction in patients with schizophrenia on antipsychotic medication
Üçok, A., İncesu, C., Aker, T., & Erkoç, Ş. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2007.01.001 · Cited by 104 · see citing works
Melkersson, K. I., Hulting, A., & Rane, A. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01352.x · Cited by 99 · see citing works
Kinon, B., AHL, J. S. B., Liu‐Seifert, H., & Maguire, G. A. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.12.006 · Cited by 94 · see citing works
Howes, O. D., Wheeler, M. J., Pilowsky, L. S., Landau, S., Murray, R. M., & Smith, S. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0302 · Cited by 93 · see citing works
Kelly, D. L., & Conley, R. R. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.010 · Cited by 88 · see citing works
Inhibin B levels in azoospermic subjects with cytologically characterized testicular pathology
Foresta, C., Bettella, A., Petraglia, F., Pistorello, M., Luisi, S. V., & Rossato, M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00659.x · Cited by 85 · see citing works
Ko, Y., Jung, S.-W., Joe, S.-H., Lee, C. H., Jung, H.-G., Jung, I., Kim, S., & Lee, M. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.02.002 · Cited by 85 · see citing works
Risperidone versus olanzapine for schizophrenia
Jayaram, M., Hosalli, P., & Stroup, T. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005237.pub2 · Cited by 83 · see citing works
Evaluation of serum steroid hormones in schizophrenic patients.
Taherianfard, M., & Shariaty, M. (2004) · PubMed · Cited by 75 · see citing works
Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia
Zhong, K., Sweitzer, D. E., Hamer, R. M., & Lieberman, J. A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0712 · Cited by 65 · see citing works
Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia
Meaney, A. M., & O’Keane, V. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01775-7 · Cited by 64 · see citing works
Serum inhibin B levels in males with gonadal dysfunction
Kolb, B. A., Stanczyk, F. Z., & Sokol, R. Z. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00641-5 · Cited by 60 · see citing works
Antipsychotic Drugs and Reproductive Hormones Relationship to Body Weight Regulation
Baptista, T. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00188-9 · Cited by 57 · see citing works
The clinical and biologic significance of serum inhibins in subfertile men
Mahmoud, A., Comhaire, F. H., & Depuydt, C. (1998) · Reproductive Toxicology · doi:10.1016/s0890-6238(98)00042-2 · Cited by 57 · see citing works
A 6-Month Prospective Observational Study on the Effects of Quetiapine on Sexual Functioning
Montejo, A. L., Rico‐Villademoros, F., Tafalla, M., & Majadas, S. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000186872.04984.56 · Cited by 48 · see citing works
Kaneda, Y., & Fujii, A. (2000) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00103-7 · Cited by 44 · see citing works
García‐Cabeza, I., Gómez, J.-C., Sacristán, J. A., Edgell, E. T., & de Chávez, M. G. (2001) · BMC Psychiatry · doi:10.1186/1471-244x-1-7 · Cited by 43 · see citing works
Effects of dopamine blockade on gonadotropins and testosterone in men
Sg, S., Siris, E. S., van Kammen, D. P., Docherty, J. P., Alexander, P. E., & Bunney, W. E. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.2.211 · Cited by 38 · see citing works
Clinical studies: inhibin in the adult male
Anderson, R. A. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00510-x · Cited by 38 · see citing works
Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients
Brunelleschi, S. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00174-9 · Cited by 27 · see citing works
Markianos, M., Hatzimanolis, J., & Lykouras, L. (1999) · Psychopharmacology · doi:10.1007/s002130050946 · Cited by 21 · see citing works
Drug-Induced Infertility and Sexual Dysfunction
Forman, R. G., Gilmour-White, S. K., & Forman, N. H. (1996) · Cambridge University Press eBooks · doi:10.1017/cbo9780511663338 · Cited by 20 · see citing works
Kaneda, Y. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200311000-00005 · Cited by 14 · see citing works
Influence of Sulpiride-Induced Hyperprolactinemia on Baboon Menstrual Cycles: a Longitudinal Study
Asô, T., Matsuoka, M., SU, J.-H., Horie, K., Taii, S., Motohashi, T., & Nishimura, T. (1982) · Journal of Medical Primatology · doi:10.1159/000460020 · Cited by 12 · see citing works
Antipsychotics and hypogonadism in patients with schizophrenia
Smith, S. M., Wheeler, M., O’Keane, V., & Murray, R. M. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)90845-4 · Cited by 4 · see citing works
Karlsson, H., Bachmann, S., Jones‐Brando, L. V., Schröder, J., Bayer, T. A., Falkai, P., McArthur, J. C., Torrey, E. F., & Yolken, R. H. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)90347-5 · Cited by 2 · see citing works
Sexual and reproductive function
Forman, R. G., Gilmour-White, S. K., & Forman, N. H. (1996) · Cambridge University Press eBooks · doi:10.1017/cbo9780511663338.002 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · see citing works
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350 · see citing works
Peripheral oxytocin is associated with reduced symptom severity in schizophrenia
Rubin, L. H., Carter, C. S., Drogos, L. L., Pournajafi‐Nazarloo, H., Sweeney, J. A., & Maki, P. M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.014 · Cited by 228 · see citing works
Kinon, B. J., Chen, L., Ascher‐Svanum, H., Stauffer, V. L., Kollack‐Walker, S., Zhou, W., Kapur, S., & Kane, J. M. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.164 · Cited by 180 · see citing works
Sexual Dysfunction in First-Episode Schizophrenia Patients
Malík, P., Kemmler, G., Hummer, M., Riecher‐Rössler, A., Kahn, R. S., & Fleischhacker, W. W. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182199bcc · Cited by 115 · see citing works
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia
Fleischhacker, W. W., Gopal, S., Lane, R., Gassmann-Mayer, C., Lim, P., Hough, D. W., Remmerie, B. M. M., & Eerdekens, M. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001076 · Cited by 115 · see citing works
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics
Torre, A. L., Conca, A., Duffy, D., Giupponi, G., Pompili, M., & Grözinger, M. (2013) · Pharmacopsychiatry · doi:10.1055/s-0033-1347177 · Cited by 107 · see citing works
Barnes, M. R., Huxley‐Jones, J., Maycox, P. R., Lennon, M. G., Thornber, A., Kelly, F., Bates, S., Taylor, A. R., Reid, J. L., Jones, N. A., et al. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22647 · Cited by 95 · see citing works
A UK epidemic of testosterone prescribing, 2001–2010
Gan, E. H., Pattman, S., Pearce, S. H. S., & Quinton, R. (2013) · Clinical Endocrinology · doi:10.1111/cen.12178 · Cited by 86 · see citing works
Risk of osteoporosis and fracture incidence in patients on antipsychotic medication
Graham, S. M., Howgate, D. J., Anderson, W. C., Howes, C., Heliotis, M., Mantalaris, A., Tsiridis, E. E., & Tsapakis, E.-M. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.560112 · Cited by 57 · see citing works
Converging evidence of blood-based biomarkers for schizophrenia
Chan, M. K., Guest, P. C., Levin, Y., Umrania, Y., Schwarz, E., Bahn, S., & Rahmoune, H. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00005-5 · Cited by 53 · see citing works
The influence of atypical antipsychotic drugs on sexual function
Just, M. J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s84528 · Cited by 49 · see citing works
Sexual dysfunctions in schizophrenia: Beyond antipsychotics. A systematic review
Dumontaud, M., Korchia, T., Khouani, J., Lançon, C., Auquier, P., Boyer, L., & Fond, G. B. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109804 · Cited by 49 · see citing works
Binder, M. D., Detraux, J., & Peuskens, J. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.906579 · Cited by 47 · see citing works
van Rijn, S., Aleman, A., de Sonneville, L. M. J., Sprong, M., Ziermans, T. B., Schothorst, P. F., van Engeland, H., & Swaab, H. (2011) · Psychological Medicine · doi:10.1017/s0033291710002576 · Cited by 47 · see citing works
Psychotropics and Male Reproduction
Drobnis, E. Z., & Nangia, A. K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-69535-8_8 · Cited by 46 · see citing works
Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
Montejo, A. L., de Alarcón, R., Prieto, N., Acosta, J. M., Buch-Vicente, B., & Montejo, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020308 · Cited by 43 · see citing works
The rate of change in declining steroid hormones: a new parameter of healthy aging in men?
Walther, A., Philipp, M., Lozza, N., & Ehlert, U. (2016) · Oncotarget · doi:10.18632/oncotarget.11752 · Cited by 40 · see citing works
Structured review of the use of the Arizona sexual experiences scale in clinical settings
Elnazer, H. Y., & Baldwin, D. S. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2730 · Cited by 37 · see citing works
Qiao, Y., Yang, F., Li, C., Guo, Q., Wen, H., Zhu, S., Ouyang, Q., Shen, W., & Sheng, J. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.12.033 · Cited by 34 · see citing works
Endocrine and testicular changes induced by olanzapine in adult Wistar rats
Bringel, S. D. S., Júnior, A. A. D. A., Amorim, M. J. A. A. L., Brito, L. T., de Morais, R. N., de Torres, S. M., Tenório, B. M., & da Silva, V. A. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1702 · Cited by 27 · see citing works
Soliman, H. M., Wagih, H. M., Attia, G. M., & Algaidi, S. A. (2014) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2014.0038 · Cited by 26 · see citing works
Olanzapine induced reproductive toxicity in male rats
Ardıç, M., Ilgın, S., Baysal, M., Karaduman, A. B., Kılıç, V., Kılıç, G., Uçarcan, Ş., & Eklioğlu, Ö. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-84235-4 · Cited by 26 · see citing works
Mishra, A. C., & Mohanty, B. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109348162 · Cited by 22 · see citing works
Ilgın, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117704 · Cited by 21 · see citing works
Kashem, M. A., Ummehany, R., Ukai, W., Hashimoto, E., Saito, T., McGregor, I. S., & Matsumoto, I. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.05.007 · Cited by 21 · see citing works
Mahmoud, G. S., Sayed, S. A., Abdelmawla, S. N., & Amer, M. A. (2019) · PubMed Central · Cited by 20 · see citing works
Antipsychotic-Induced Hyperprolactinemia and Testosterone Levels in Boys
Roke, Y., van Harten, P. N., Buitelaar, J. K., Tenback, D. E., de Rijke, Y. B., & Boot, A. M. (2012) · Hormone Research in Paediatrics · doi:10.1159/000337910 · Cited by 20 · see citing works
The Association Between Psychotropic Drug Use and Fertility Problems Among Male Subjects
Solomon, R., Shvartsur, R., & Azab, A. N. (2019) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000353 · Cited by 18 · see citing works
Mishra, A. C., & Mohanty, B. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.014 · Cited by 17 · see citing works
Psychiatric Patients with Antipsychotic Drug-Induced Hyperprolactinemia and Menstruation Disorders
Takechi, K., Yoshioka, Y., Kawazoe, H., Tanaka, M., Takatori, S., Kobayashi, M., Matsuoka, I., Yanagawa, H., Zamami, Y., Imanishi, M., et al. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00053 · Cited by 13 · see citing works
Antipsychotic-Induced Weight Gain and Clinical Improvement: A Psychiatric Paradox
García‐Rizo, C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.560006 · Cited by 12 · see citing works
Piriu, G., Torac, E., Gaman, L. E., Iosif, L., Tivig, I. C., Delia, C., Gîlcă, M., Stoian, I. A.-M., & Atanasiu, V. (2015) · Europe PMC (PubMed Central) · Cited by 11 · see citing works
The central mechanism of risperidone-induced hyperprolactinemia
Sun, W., Li, L., Huang, X., Shi, Y., Yang, H.-Q., Song, Z.-Y., & Lin, S. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.009 · Cited by 10 · see citing works
Nikolić‐Kokić, A., Tatalović, N., Brkljačić, J. M., Mijović, M., Nestorović, V., Mijušković, A., Oreščanin-Dušić, Z., Uzelac, T. V., Nikolic, M. R., Spasić, S. D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213698 · Cited by 8 · see citing works
Ateş, M. A., Tutuncu, R., Oner, I., Ercan, S., Başoğlu, C., Algül, A., Balıbey, H., İpçioğlu, O. M., Çetin, M., & Ebrinç, S. (2015) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20141212113905 · Cited by 8 · see citing works
Downregulated StAR gene and male reproductive dysfunction caused by nifedipine and ethosuximide
Ebiya, R. A., Montaser, M. M., & Darwish, S. M. (2016) · The Journal of Basic and Applied Zoology · doi:10.1016/j.jobaz.2016.12.005 · Cited by 7 · see citing works
Shen, H., Wu, D., Wang, S., Zhao, M., Sun, W., Zhu, X., Zhang, N., Yao, H. Q., Cui, Q., & Xiao, H. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13079 · Cited by 7 · see citing works
The longitudinal course of schizophrenia: testosterone and progression of the negative symptoms
Sisek-Šprem, M., Gradiški, I. P., Žaja, N., & Herceg, M. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1681509 · Cited by 7 · see citing works
Dinçer, B., Yazıcı, A. B., Çınar, İ., Toktay, E., Selli, J., Çadırcı, E., Bayraktutan, Z., & Yazıcı, E. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202201190 · Cited by 6 · see citing works
Ramin, T., Peter, J., Schneider, M., Dahling, V., & Zolk, O. (2025) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70142 · Cited by 5 · see citing works
Konarzewska, B., Galińska-Skok, B., Waszkiewicz, N., Łazarczyk-Kirejczyk, J., Małus, A., Simonienko, K., & Szulc, A. (2014) · PubMed · Cited by 6 · see citing works
Self-citationPark, E. J., & Park, Y. (2015) · Psychiatry Investigation · doi:10.4306/pi.2015.12.1.55 · Cited by 6 · see citing works
Samadi, A., Işıkhan, S. Y., Khadem, A. M., Samadi, M., & Sabuncuoğlu, S. (2019) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_145_18 · Cited by 6 · see citing works
Syed, M., Akram, W., & Faruqi, N. (2019) · Journal of Anatomical Society of India · doi:10.4103/jasi.jasi_43_19 · Cited by 5 · see citing works
Kruse, G. B., Wong, B. J. O., Duh, M. S., Lefèbvre, P., Lafeuille, M., & Fastenau, J. M. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0285-8 · Cited by 5 · see citing works
A 12-week intramuscular toxicity study of risperidone-loaded microspheres in Beagle dogs
Tian, J., Wang, W., Ye, L., Cen, X., Guan, X., Zhang, J., Yu, P., Du, G., Liu, W., & Li, Y. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113499045 · Cited by 5 · see citing works
Growing Up Fast: Managing Autism Spectrum Disorder and Precocious Puberty
Finkle, A. E., Zavertnik, S., Myers, S. E., Cormier, D., Heithaus, J. L., & Augustyn, M. C. (2020) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000865 · Cited by 4 · see citing works
Menstrual Dysfunction in Women With Schizophrenia During Risperidone Maintenance Treatment
Bo, Q., Xing, X., Tian, L., Mao, Z., Zhou, F., & Wang, C. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001344 · Cited by 4 · see citing works
Neuroleptic-Associated Hyperprolactinemia: Clinical Manifestations and Effects on Sexual Function
Yunilaynen, O. A., Starostina, E. G., Dzeranova, L. K., Kudryashkina, G. N., Kessel'man, L. G., Баранов, П. А., & Dedov, I. I. (2018) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-018-0571-y · Cited by 3 · see citing works
Histological Changes of Aripiprazole on the Seminiferous Tubules of Prepubertal Albino Rats
Rizkalla, N., Habib, E. K., Amin, M. A., & Aziz, D. (2017) · The Egyptian Journal of Anatomy · doi:10.21608/ejana.2018.16910 · Cited by 2 · see citing works
Switching to quetiapine for risperidone-induced amenorrhea: Report of two cases
Pardal, P., Konwar, R., & Prakash, J. (2010) · Industrial Psychiatry Journal · doi:10.4103/0972-6748.90348 · Cited by 2 · see citing works
Psychosis, Antipsychotic Medication, and Sexual Dysfunctions
Hert, M. D., & Detraux, J. (2018) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-68306-5_8 · Cited by 2 · see citing works
Yunilaynen, O. A., Starostina, E. G., Dzeranova, L. K., Kudryashkina, G. N., Kessel'man, L. G., Баранов, П. А., & Dedov, I. I. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201611611117-25 · Cited by 1 · see citing works
Shettima, F. B., Wakil, M. A., Sheikh, T. L., Abdulaziz, M., Rabbebe, I. B., Wakawa, I. A., & Ogualili, P. N. (2023) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174231196612 · Cited by 1 · see citing works
Khattab, M. A. A., Ahmed, S. M., Salama, H. G., & Mekawy, N. H. (2025) · Ultrastructural Pathology · doi:10.1080/01913123.2025.2495159 · Cited by 1 · see citing works
Николаевна, Г. Л., Доровских, И. В., Литвинов, А. В., Сергеевич, Б. В., Gamdullaev, S. K., & Pavlova, T. A. (2023) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2023-714 · Cited by 1 · see citing works
Bashandy, S. A. E., Morsy, F. A., Bashandy, Y. S., Elbaset, M. A., & Mohamed, B. M. S. A. (2025) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2025.100043 · Cited by 1 · see citing works
Гиперпролактинемия,ассоциированная с приемом нейролептиков
Yunilaynen, O. A., & Владимирович, Д. И. (2013) · Социальная и клиническая психиатрия
Gardner, D. M., Teehan, M. D., & Baldessarini, R. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511919237.020
Jha, S., & Garg, A. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.066
Medicamentos como posible factor asociado a la infertilidad masculina
Martínez, B. C. (2015) · Farmacéuticos Comunitarios · doi:10.5672/fc.2173-9218.(2015/vol7).003.05
Maj, M., Ïðåçèäåíò, È., Tasman, A., & Herrman, H. (2011)
Shindalla, O. M. Y., Othman, S. H., & Thanoon, I. A. J. (2011) · Annals of the College of Medicine Mosul/Annals of the College of Medecine · doi:10.33899/mmed.2011.35778
Disfunzioni sessuali nei trattamenti con farmaci antipsicotici
Lombardo, L., & Rossi, R. (2017) · RIVISTA DI SESSUOLOGIA CLINICA · doi:10.3280/rsc2017-002001
Current awareness in human psychopharmacology
(2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.976
Developing a rodent model for antipsychotic-induced metabolic adverse effects
Skrede, S. (2012) · NORA - Norwegian Open Research Archives
Constantin, É., Deol, M. S., Yaun, J., Singh, H., & Glass, O. (2026) · Case Reports in Psychiatry · doi:10.1155/crps/9442957
- Authors
- Konarzewska, B., Wołczyński, S., Szulc, A., Galińska, B., Popławska, R., & Waszkiewicz, N.
- Affiliations
- Medical University of Białystok (PL)
- Corresponding author
- Konarzewska, Beata
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 34
- Issue
- 1
- Pages
- 129-139
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W1989456744
- Cited by
- 70
- References
- 59
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 4 · 2013: 6 · 2012: 2
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychoneuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- olanzapine, schizophrenia, male patients, hyperprolactinemia, hypothalamic-pituitary-gonadal axis, testosterone, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, sexual dysfunction, medication adherence, antipsychotic drugs, antipsychotic adverse effects, Leydig cell dysfunction, Sertoli cell dysfunction
- MeSH terms
- Olanzapine, Adult, Benzodiazepines, Estradiol, Gonadotropins, Pituitary, Hormones, Humans, Hyperprolactinemia, Inhibins, Male, Patient Compliance, Prolactin, Schizophrenia, Schizophrenic Psychology, Severity of Illness Index, Sexual Dysfunction, Physiological, Testosterone, Antipsychotic Agents, Risperidone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
